Clinical Trial Update: A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing surgery with sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Portal Vein Tumor Thrombus | Phase 4 | Status: UNKNOWN